Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

SSR-69071 selected for development as an HLE inhibitor for respiratory diseases

Sep. 4, 2002

Bladder-selective potassium channel openers described by Abbott and ICAgen

Sep. 4, 2002

Spanish investigators discover potent and selective inhibitor of the endocannabinoid transporter

Sep. 4, 2002

Potential new therapeutic for functional dyspepsia presented at medicinal chemistry meeting

Sep. 4, 2002

Pharmacodynamic and pharmacokinetic profile of fesoterodine

Sep. 4, 2002

Systemic ECE and NEP inhibition in humans treated with SLV-306

Sep. 3, 2002

NNC-25-2504: a glucagon antagonist that inhibits hepatic glucose production

Sep. 3, 2002

Potential new agent for stress urinary incontinence in development at Roche Bioscience

Sep. 3, 2002

Long-acting DAC:GLP-1 analogue effective and well tolerated in preclinical studies

Sep. 3, 2002

Different effects of thiazolidinediones on adipogenesis

Sep. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...